BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 26812401)

  • 1. Breaking Down the Barriers in Complicated Pleural Sepsis.
    Vorster MJ; Koegelenberg CF
    Respiration; 2016; 91(2):99-100. PubMed ID: 26812401
    [No Abstract]   [Full Text] [Related]  

  • 2. The first use of combination of Intrapleural Fibrinolytics (Alteplase & DNAse) for pleural infection in Malaysia.
    Muhammad Redzwan SRA
    Med J Malaysia; 2019 Apr; 74(2):176-178. PubMed ID: 31079131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of Noncommunicating Multiloculated Pleural Space Infection With Fibrinolytic Augmented Multiple Chest Tube Drainage.
    Biswas A; Jantz MA; Barnes MD; Mehta HJ
    J Bronchology Interv Pulmonol; 2016 Apr; 23(2):e14-7. PubMed ID: 27058724
    [No Abstract]   [Full Text] [Related]  

  • 4. Concurrent Versus Sequential Intrapleural Instillation of Tissue Plasminogen Activator and Deoxyribonuclease for Pleural Infection.
    Kheir F; Cheng G; Rivera E; Folch A; Folch E; Fernandez-Bussy S; Keyes C; Parikh M; Channick C; Chee A; Majid A
    J Bronchology Interv Pulmonol; 2018 Apr; 25(2):125-131. PubMed ID: 29346247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of Intrapleural Sepsis with Once Daily Use of Tissue Plasminogen Activator and Deoxyribonuclease.
    Mehta HJ; Biswas A; Penley AM; Cope J; Barnes M; Jantz MA
    Respiration; 2016; 91(2):101-6. PubMed ID: 26761711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current use of intrapleural tissue plasminogen activator in the treatment of complex pleural processes: a review of the literature and report of 9 cases.
    Dulaney CR; Merrill WH; Tesseneer S; Jenkins-Lonidier L; Tribble CG
    J Miss State Med Assoc; 2012 Jul; 53(7):216-9. PubMed ID: 23066590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue plasminogen activator and DNase in empyema.
    Simons SO; Smits D; van der Heijden E
    N Engl J Med; 2011 Nov; 365(20):1936; author reply 1936-7. PubMed ID: 22087692
    [No Abstract]   [Full Text] [Related]  

  • 8. Tissue plasminogen activator and DNase in empyema.
    Bachmayer K
    N Engl J Med; 2011 Nov; 365(20):1936; author reply 1936-7. PubMed ID: 22087691
    [No Abstract]   [Full Text] [Related]  

  • 9. Intrapleural agents for pleural infection: fibrinolytics and beyond.
    Rahman NM
    Curr Opin Pulm Med; 2012 Jul; 18(4):326-32. PubMed ID: 22487944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical assessment of adjunctive tPA and DNase for peritoneal dialysis associated peritonitis.
    McGuire AL; Bennett SC; Lansley SM; Popowicz ND; Varano della Vergiliana JF; Wong D; Lee YC; Chakera A
    PLoS One; 2015; 10(3):e0119238. PubMed ID: 25742006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bacterial enzymes in the treatment of purulent infections].
    Grigorian AV; Tapinskiĭ LS; Lokhvitskiĭ SV; Gostishchev VK; Galach'iants OP; Prishchep MK
    Sov Med; 1967 Dec; 30(12):39-45. PubMed ID: 5606289
    [No Abstract]   [Full Text] [Related]  

  • 12. Effectiveness and risks associated with intrapleural alteplase by means of tube thoracostomy.
    Ben-Or S; Feins RH; Veeramachaneni NK; Haithcock BE
    Ann Thorac Surg; 2011 Mar; 91(3):860-3; discussion 863-4. PubMed ID: 21353015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrapleural fibrinolytics combined with image-guided chest tube drainage for pleural infection.
    Levinson GM; Pennington DW
    Mayo Clin Proc; 2007 Apr; 82(4):407-13. PubMed ID: 17418067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of local treatment of pleural aspergillosis].
    Krakówka P; Halweg H; Walczak J; Traczyk K
    Pneumonol Pol; 1979 Dec; 47(12):841-7. PubMed ID: 395511
    [No Abstract]   [Full Text] [Related]  

  • 15. "Less Is More" Approach for Management of Intrapleural Sepsis.
    Biswas A; Jantz MA; Mehta HJ
    Ann Am Thorac Soc; 2017 Aug; 14(8):1355-1356. PubMed ID: 28622017
    [No Abstract]   [Full Text] [Related]  

  • 16. Tissue plasminogen activator for the treatment of parapneumonic effusions in pediatric patients.
    Israel EN; Blackmer AB
    Pharmacotherapy; 2014 May; 34(5):521-32. PubMed ID: 24390857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrapleural tissue plasminogen activator and deoxyribonuclease for pleural infection. An effective and safe alternative to surgery.
    Piccolo F; Pitman N; Bhatnagar R; Popowicz N; Smith NA; Brockway B; Nickels R; Burke AJ; Wong CA; McCartney R; Choo-Kang B; Blyth KG; Maskell NA; Lee YC
    Ann Am Thorac Soc; 2014 Nov; 11(9):1419-25. PubMed ID: 25296241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reply: "Less Is More" Approach for Management of Intrapleural Sepsis.
    Popowicz N; Thomas R; Lee YCG
    Ann Am Thorac Soc; 2017 Aug; 14(8):1356-1357. PubMed ID: 28622018
    [No Abstract]   [Full Text] [Related]  

  • 19. [Selective thrombolysis with recombinant tissue type plasminogen activator in combination with prostaglandin E1].
    Bertuch H; Pilger E; Stark G; Lammer J
    Vasa Suppl; 1989; 27():240. PubMed ID: 2516366
    [No Abstract]   [Full Text] [Related]  

  • 20. Tissue plasminogen activator combined with human recombinant deoxyribonuclease is effective therapy for empyema in a rabbit model.
    Zhu Z; Hawthorne ML; Guo Y; Drake W; Bilaceroglu S; Misra HL; Light RW
    Chest; 2006 Jun; 129(6):1577-83. PubMed ID: 16778278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.